Bio Green Med Solution Inc
BGMS
3 hedge funds and large institutions have $833K invested in Bio Green Med Solution Inc in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
171% more capital invested
Capital invested by funds: $307K → $833K (+$526K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$291K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$58.2K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$16K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$2K |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
-$1K |
BGMS Hedge Fund Activity: Q1 2019 in Review
3 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q1 2019, worth a combined $833K — up 171% from $307K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $291K. The largest seller was Virtu Financial, exiting entirely with an estimated $58.2K sold.
- 3 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q1 2019, down from 4 in Q4 2018.
- Funds reported $833K of Bio Green Med Solution Inc stock for Q1 2019, up 171% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc positions in Q1 2019 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc buyer in Q1 2019 was Renaissance Technologies, an estimated $291K added.
- The largest Bio Green Med Solution Inc seller in Q1 2019 was Virtu Financial, an estimated $58.2K sold.
Based on aggregated 13F filings for Q1 2019.